2025 to 2026 Legislature · State Senate bill

SB 492

Relating to: coverage of nonopioid drug alternatives for the treatment and management of pain.

In committee Last action March 23, 2026: Failed to pass pursuant to Senate Joint Resolution 1

Official bill page and text: docs.legis.wisconsin.gov

Sponsors 3

Prime sponsors

Dassler-Alfheim, James, Keyeski

Status

In committee as of March 23, 2026. The 2025 to 2026 Legislature serves until the 2027 Legislature convenes on January 4, 2027.

Referred to: Senate Mental Health, Substance Abuse Prevention, Children and Families (from the official referral record)

Roll-call votes 0

No roll-call votes recorded for this measure.

Timeline 10

Date	Chamber	Action
March 23, 2026	Senate	Failed to pass pursuant to Senate Joint Resolution 1
January 22, 2026	Senate	Available for scheduling
January 22, 2026	Senate	Report passage by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 2, Noes 3
January 22, 2026	Senate	Executive action taken
January 22, 2026	Senate	Senator Keyeski withdrawn as a coauthor
December 16, 2025	Senate	Senate Amendment 1 offered by Senator James
October 8, 2025	Senate	Public hearing held
October 7, 2025	Senate	Commissioner of Insurance report received pursuant to s.601.423(2), Wisconsin Statutes
October 2, 2025	Senate	Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families
October 2, 2025	Senate	Introduced by Senators James, Dassler-Alfheim and Keyeski; cosponsored by Representatives Moses, Armstrong, Behnke, Duchow, Gundrum, Knodl, Melotik, Mursau, O'Connor, Wichgers and Murphy

Data: Open States (bulk data, October 1, 2026 monthly extract, which has no roll-call tallies; public data, attribution appreciated). Official record: docs.legis.wisconsin.gov. Bill pages link to the official text, not copied.